TARS
Tarsus Pharmaceuticals, Inc.
TARS
Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. (TARS) Q2 2026 Earnings Call Transcript
Tarsus Pharmaceuticals NASDAQ: TARS said it has closed its acquisition of iRenix Medical, Inc., adding IRX-101, a late-stage investigational ocular surface antiseptic, to its pipeline as the company s
Tarsus Pharmaceuticals, Inc. (TARS) M&A Call Transcript